NCT03950700View on ClinicalTrials.gov

Bupivacaine in the Treatment of Postoperative Pain of Impacted Third Molar Extraction

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

January 1, 2020

Conditions

Teeth, Impacted

Interventions

DRUG

Bupivacaine-epinephrine

BUPIROP® 0.5% ROPSOHN THERAPEUTICS S.A.S

DRUG

Saline Solution

Saline solution 0.9% (Baxter laboratories).

Trial Locations (1)

Unknown

CES University, Medellín

Sponsors

Lead Sponsor

All Listed Sponsors

lead

CES University

OTHER